Hibiscus

What Is Hibiscus?

Hibiscus rosa-sinensis, the Chinese hibiscus or shoeflower, is a glossy-leaved evergreen shrub grown throughout the tropics for its large, showy red flowers. It is a mallow-family relative of okra and cotton and is among the most widely cultivated ornamental shrubs in the world, with a long history of use in Asian traditional medicine and cosmetics.

Traditional & Modern Uses

In Ayurveda and Chinese folk medicine the flowers and leaves are used as a cooling, mildly relaxing remedy, for hair and scalp care, and as a gentle remedy for cough and menstrual complaints. The flowers are infused as a tea and the mucilaginous leaves used as an emollient. Ayurvedic practice also uses the flower as an emmenagogue and traditional contraceptive — the use that underlies its caution in pregnancy. Modern interest centres on the antioxidant pigment content and possible mild blood-pressure-lowering and relaxant effects.

Phytochemistry

The deep red flowers owe their colour to anthocyanins, chiefly cyanidin-3-sophoroside, which is the major pigment of the red cultivars and is absent from white and yellow forms ^{3Reference 3Mejía et al. · 2023Color, antioxidant capacity and flavonoid composition in Hibiscus rosa-sinensis cultivars — analytical (UHPLC-MS)View study →}. Alongside the pigments sit antioxidant flavonols — quercetin, kaempferol and rutin — while the leaves are rich in a soothing, gel-forming mucilage that accounts for their traditional emollient use ^{1Reference 1Amtaghri et al. · 2024ReviewA comprehensive overview of Hibiscus rosa-sinensis L.: ethnobotany, phytochemistry, therapeutic uses, pharmacology and toxicology — reviewView study →}. (Note that the tart “hibiscus tea” of commerce is usually the related species Hibiscus sabdariffa, not this ornamental.)

Constituent Summary

Flower aglycone figures are mg per gram of fresh petal tissue and vary strongly with petal colour (red cultivars carry the most anthocyanin and the least flavonol) ^{3Reference 3Mejía et al. · 2023Color, antioxidant capacity and flavonoid composition in Hibiscus rosa-sinensis cultivars — analytical (UHPLC-MS)View study →}. Entries marked No Data are documented qualitatively only.

Pharmacology & Research

Hibiscus rosa-sinensis — the ornamental Chinese hibiscus or shoeflower — carries a broad but almost entirely preclinical literature (~260 PubMed records), and the first thing to untangle is a species confusion baked into “hibiscus” research: the famous blood-pressure and lipid RCTs are on the tart tea species Hibiscus sabdariffa (roselle), a different plant, and essentially none of that human evidence transfers to this glossy-leaved ornamental ^{1,2Reference 1Amtaghri et al. · 2024ReviewA comprehensive overview of Hibiscus rosa-sinensis L.: ethnobotany, phytochemistry, therapeutic uses, pharmacology and toxicology — reviewView study →Reference 2Raza et al. · 2025ReviewHibiscus rosa-sinensis: a multifunctional flower bridging nutrition, medicine, and molecular therapeutics — reviewView study →}. For rosa-sinensis itself the strongest and most replicated signals are its cultivar-dependent antioxidant flavonoid content, a robust animal antifertility/anti-implantation effect that anchors the pregnancy warning, and a consistent antihyperglycaemic effect in diabetic rodents. Wound-healing, vasorelaxant, anti-inflammatory, neurobehavioural, antimicrobial and hair-growth effects are all documented but rest on single or small clusters of animal and in-vitro studies. No registered clinical trial exists for any indication in this species — the evidence base is preclinical throughout, and results obtained with solvent-standardised extracts do not necessarily carry over to the flower tea or leaf mucilage as traditionally used.

0. Evidence by indication

Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric, and I’ll keep honing the formula over time. Each indication name links down to its write-up.

Indication	Support	Rests on
Antioxidant	███████░░░ 72%	Well-characterised anthocyanin/flavonol content and consistent radical-scavenging assays across cultivars; in-vitro plus in-vivo diabetic-rat antioxidant data, no human 3,4,5Reference 3Mejía et al. · 2023Color, antioxidant capacity and flavonoid composition in Hibiscus rosa-sinensis cultivars — analytical (UHPLC-MS)View study →Reference 4Kumar et al. · 2012AnimalAntidyslipidemic and antioxidant activity of Hibiscus rosa-sinensis root extract in alloxan-induced diabetic rats — in vivoView study →Reference 5Khan et al. · 2014In vitroAntioxidant and antibacterial activities of Hibiscus rosa-sinensis Linn. flower extracts — in vitroView study →.
Antifertility / anti-implantation	██████░░░░ 64%	Old but replicated rodent studies — flower extracts show post-coital anti-implantation and antispermatogenic effects; drives the pregnancy caution 16,17,18,19Reference 16Kholkute et al. · 1977AnimalAntifertility potentiality of Hibiscus rosa-sinensis: parts of medicinal value, species and seasonal variation — ratView study →Reference 17Kholkute · 1977AnimalEffect of Hibiscus rosa-sinensis on spermatogenesis and accessory reproductive organs in rats — in vivoView study →Reference 18Singh et al. · 1982AnimalAntifertility activity of a benzene extract of Hibiscus rosa-sinensis flowers in female rats — in vivoView study →Reference 19Pal et al. · 1985AnimalFlowers of Hibiscus rosa-sinensis, a potential contragestative agent: anti-implantation effect of the benzene extract — in vivoView study →.
Antidiabetic / antihyperglycaemic	██████░░░░ 62%	Multiple diabetic-rat studies; flower and leaf extracts lower glucose via glycogen-metabolism, β-cell, AMPK and carbohydrate-digestion effects. Consistent but animal-only 8,9,10,11,12,29Reference 8Pillai et al. · 2016AnimalHibiscus rosa-sinensis petals modulate glycogen metabolism and glucose-homeostasis signalling in diabetic rats — in vivoView study →Reference 9Pillai et al. · 2018In vitroHibiscus rosa-sinensis petals attenuate high-glucose-induced apoptotic and inflammatory signalling in pancreatic β-cells — in vitroView study →Reference 10Lingesh et al. · 2019In vitroAMPK-activating and anti-adipogenic potential of Hibiscus rosa-sinensis flower in 3T3-L1 cells — in vitroView study →Reference 11Sachdewa et al. · 2001AnimalHypoglycaemic effect of Hibiscus rosa-sinensis leaf extract in diabetic rats — in vivoView study →Reference 12Sachdewa et al. · 1999AnimalA preliminary investigation of the possible hypoglycaemic activity of Hibiscus rosa-sinensis — in vivoView study →Reference 29Ansari et al. · 2020In vitroAnti-hyperglycaemic activity of Hibiscus rosa-sinensis leaves via carbohydrate-digestion inhibition and enhanced insulin secretion — in vivo/in vitroView study →.
Wound healing	██████░░░░ 57%	Flower extracts accelerate closure and boost tensile strength/collagen in rats; three animal studies, no human 13,14,15Reference 13Nayak et al. · 2007AnimalWound-healing activity of Hibiscus rosa-sinensis flower extract in rats — in vivoView study →Reference 14Bhaskar et al. · 2012AnimalWound-healing activity of ethanolic Hibiscus rosa-sinensis flower extract in rats (excision/incision/dead-space) — in vivoView study →Reference 15Shen et al. · 2017AnimalN-butanol fraction of Hibiscus rosa-sinensis flowers enhances excisional wound healing in rats — in vivoView study →.
Antihypertensive / vasorelaxant	█████░░░░░ 54%	Endothelium-independent aortic relaxation and BP lowering in hypertensive rats only; small, and confounded by sabdariffa literature 6,7Reference 6Amtaghri et al. · 2022In vitroAntihypertensive and vasorelaxant effects of Hibiscus rosa-sinensis via ACE-2 and Ca²⁺-channel pathways — in vivo/in vitro (rat)View study →Reference 7Mohan et al. · 2012AnimalEffect of aqueous Hibiscus rosa-sinensis on blood pressure and metabolic alterations in fructose-induced hypertensive rats — in vivoView study →.
Anti-inflammatory / analgesic	█████░░░░░ 51%	Root extract analgesic/anti-inflammatory; leaf extract reduces experimental colitis (TNF-α ↓). A few animal studies 21,22Reference 21Begum et al. · 2018AnimalAnalgesic and anti-inflammatory activity of the ethanol extract of Hibiscus rosa-sinensis roots — rodent modelsView study →Reference 22Kandhare et al. · 2012AnimalHydroalcoholic Hibiscus rosa-sinensis leaf extract in experimental colitis in rats (TNF-α ↓, antioxidant) — in vivoView study →.
Neuroprotective / CNS	█████░░░░░ 49%	Antidepressant, anxiolytic (GABA-A), neuroprotective and neurobehavioural signals in separate rat models; no convergence, no human 25,26,27,28Reference 25Begum et al. · 2018AnimalHibiscus rosa-sinensis mediates an anxiolytic effect via ionotropic GABA-A receptor modulation — ratView study →Reference 26Shewale et al. · 2012AnimalAntidepressant-like activity of anthocyanidins from Hibiscus rosa-sinensis flowers (tail-suspension/forced-swim) — miceView study →Reference 27Nade et al. · 2010AnimalNeuroprotective effect of Hibiscus rosa-sinensis in a cerebral post-ischemic reperfusion oxidative-stress model — ratView study →Reference 28Nade et al. · 2009AnimalEffect of Hibiscus rosa-sinensis on reserpine-induced neurobehavioural and biochemical alterations — ratView study →.
Antimicrobial	█████░░░░░ 48%	In-vitro activity against bacteria/fungi and antibiotic-resistant H. pylori; disc-diffusion/MIC only, clinical relevance unclear 5,23Reference 5Khan et al. · 2014In vitroAntioxidant and antibacterial activities of Hibiscus rosa-sinensis Linn. flower extracts — in vitroView study →Reference 23Ngan et al. · 2021In vitroAntibacterial activity of Hibiscus rosa-sinensis red flower against antibiotic-resistant Helicobacter pylori, with constituent identification — in vitroView study →.
Hair growth	████░░░░░░ 44%	A single rat study of leaf/flower extract promoting follicle growth, supporting long traditional cosmetic use 24Reference 24Adhirajan et al. · 2003AnimalIn-vivo and in-vitro evaluation of hair-growth potential of Hibiscus rosa-sinensis — ratView study →.
Anticancer	████░░░░░░ 38%	Mouse skin-tumour and in-silico signals; constituent-level and single-model, far from clinical 30,31Reference 30Sharma et al. · 2004AnimalPrevention of two-stage skin carcinogenesis by Hibiscus rosa-sinensis extract and its constituent gentisic acid — miceView study →Reference 31Rasul et al. · 2022In-silico screening of Hibiscus rosa-sinensis anti-cancer constituents targeting mTOR (molecular docking / pharmacokinetics)View study →.

1. Antioxidant

The antioxidant story is the best-characterised part of this plant’s chemistry. A 2023 UHPLC-Orbitrap-MS survey of 16 cultivars found that red, pink, orange and lilac flowers carry cyanidin-based anthocyanins (chiefly the sophoroside) while white and yellow forms do not, and that total flavonol content — quercetin- and kaempferol-glycosides — runs inversely to anthocyanin content ^{3Reference 3Mejía et al. · 2023Color, antioxidant capacity and flavonoid composition in Hibiscus rosa-sinensis cultivars — analytical (UHPLC-MS)View study →}. Flower extracts show concentration-dependent DPPH/ABTS radical scavenging and reducing power in vitro ^{5Reference 5Khan et al. · 2014In vitroAntioxidant and antibacterial activities of Hibiscus rosa-sinensis Linn. flower extracts — in vitroView study →}, and a root extract restored antioxidant enzymes while lowering lipids in diabetic rats ^{4Reference 4Kumar et al. · 2012AnimalAntidyslipidemic and antioxidant activity of Hibiscus rosa-sinensis root extract in alloxan-induced diabetic rats — in vivoView study →}. This is a genuine, dose-related activity, but it is measured almost entirely in chemical and animal assays and is cultivar-dependent: the “antioxidant hibiscus” claim really applies to the pigmented flowers, not white/yellow ornamentals or the leaf.

Gap: No human bioavailability or clinical antioxidant-status data; anthocyanins are poorly absorbed, so in-vitro scavenging need not translate to systemic effect.

2. Antifertility / anti-implantation

This is the oldest and most reproducibly documented pharmacology of the species. Benzene and ethanol extracts of the flowers, given post-coitally, produced significant anti-implantation and abortifacient effects in rats and altered oestrous cyclicity across several independent 1977–1985 studies ^{16,18Reference 16Kholkute et al. · 1977AnimalAntifertility potentiality of Hibiscus rosa-sinensis: parts of medicinal value, species and seasonal variation — ratView study →Reference 18Singh et al. · 1982AnimalAntifertility activity of a benzene extract of Hibiscus rosa-sinensis flowers in female rats — in vivoView study →}, with a dedicated study confirming the flowers as a benzene-extract “contragestative” agent acting through anti-implantation ^{19Reference 19Pal et al. · 1985AnimalFlowers of Hibiscus rosa-sinensis, a potential contragestative agent: anti-implantation effect of the benzene extract — in vivoView study →}; antispermatogenic effects on the male reproductive organs are also documented ^{17Reference 17Kholkute · 1977AnimalEffect of Hibiscus rosa-sinensis on spermatogenesis and accessory reproductive organs in rats — in vivoView study →}. The effect is reversible and dose-dependent, and it is the direct pharmacological basis for the traditional use as an emmenagogue/contraceptive — and therefore for avoiding the flower in pregnancy.

Gap: All rodent; no controlled human reproductive data. The active fraction and mechanism (hormonal vs. direct uterine) are not fully resolved, and doses are far above culinary tea exposure.

3. Antidiabetic / antihyperglycaemic

Flower and leaf extracts lower blood glucose in streptozotocin- and alloxan-diabetic rats fairly consistently across groups. Early work showed hypoglycaemic activity of leaf and flower extracts in diabetic rats ^{11,12Reference 11Sachdewa et al. · 2001AnimalHypoglycaemic effect of Hibiscus rosa-sinensis leaf extract in diabetic rats — in vivoView study →Reference 12Sachdewa et al. · 1999AnimalA preliminary investigation of the possible hypoglycaemic activity of Hibiscus rosa-sinensis — in vivoView study →}, and later studies tied the effect to regulation of glycogen metabolism and glucose-homeostasis signalling ^{8Reference 8Pillai et al. · 2016AnimalHibiscus rosa-sinensis petals modulate glycogen metabolism and glucose-homeostasis signalling in diabetic rats — in vivoView study →}, protection of pancreatic β-cells from glucotoxicity ^{9Reference 9Pillai et al. · 2018In vitroHibiscus rosa-sinensis petals attenuate high-glucose-induced apoptotic and inflammatory signalling in pancreatic β-cells — in vitroView study →}, AMPK activation with anti-adipogenic effects ^{10Reference 10Lingesh et al. · 2019In vitroAMPK-activating and anti-adipogenic potential of Hibiscus rosa-sinensis flower in 3T3-L1 cells — in vitroView study →}, and — for the leaves — inhibition of carbohydrate digestion and absorption alongside enhanced insulin secretion ^{29Reference 29Ansari et al. · 2020In vitroAnti-hyperglycaemic activity of Hibiscus rosa-sinensis leaves via carbohydrate-digestion inhibition and enhanced insulin secretion — in vivo/in vitroView study →}. The signal is reproducible in rodents and mechanistically plausible, and a mild hypolipidaemic effect has been reported alongside it ^{4Reference 4Kumar et al. · 2012AnimalAntidyslipidemic and antioxidant activity of Hibiscus rosa-sinensis root extract in alloxan-induced diabetic rats — in vivoView study →}. It remains entirely preclinical.

Gap: No human glycaemic trials; extract doses (often 250–500 mg/kg in rats) don’t map onto any defined human preparation or dose.

4. Wound healing

Topical application supports the traditional vulnerary use. An aqueous flower extract accelerated wound contraction, epithelialisation and tensile strength in excision and incision wounds in rats ^{13Reference 13Nayak et al. · 2007AnimalWound-healing activity of Hibiscus rosa-sinensis flower extract in rats — in vivoView study →}, and an ethanolic flower extract likewise improved breaking strength and collagen (hydroxyproline) content across excision, incision and dead-space models ^{14Reference 14Bhaskar et al. · 2012AnimalWound-healing activity of ethanolic Hibiscus rosa-sinensis flower extract in rats (excision/incision/dead-space) — in vivoView study →}; an n-butanol flower fraction enhanced healing in a comparative study ^{15Reference 15Shen et al. · 2017AnimalN-butanol fraction of Hibiscus rosa-sinensis flowers enhances excisional wound healing in rats — in vivoView study →}. The effect is credible for a mucilage- and flavonoid-rich botanical, but rests on a small cluster of animal studies.

Gap: No human wound-care data; optimal preparation (fresh mucilage vs. dried extract) and concentration undefined.

5. Antihypertensive / vasorelaxant

An aqueous flower extract (100 mg/kg orally, 7 days) lowered systolic, diastolic and mean arterial pressure in hypertensive rats without affecting normotensive animals, and relaxed isolated aortic rings through an endothelium-independent mechanism involving Ca²⁺-channel and ACE-related pathways ^{6Reference 6Amtaghri et al. · 2022In vitroAntihypertensive and vasorelaxant effects of Hibiscus rosa-sinensis via ACE-2 and Ca²⁺-channel pathways — in vivo/in vitro (rat)View study →}. A separate study reported blood-pressure and metabolic benefits in fructose-induced hypertensive rats ^{7Reference 7Mohan et al. · 2012AnimalEffect of aqueous Hibiscus rosa-sinensis on blood pressure and metabolic alterations in fructose-induced hypertensive rats — in vivoView study →}. The signal is real but small and species-specific: most human “hibiscus lowers blood pressure” evidence belongs to H. sabdariffa, and should not be read onto this ornamental.

Gap: No human data for rosa-sinensis; effect seen only in already-hypertensive animals, and the traditional preparation (flower tea) has never been tested for this.

6. Anti-inflammatory / analgesic

An ethanolic root extract showed analgesic and anti-inflammatory activity in standard rodent models ^{21Reference 21Begum et al. · 2018AnimalAnalgesic and anti-inflammatory activity of the ethanol extract of Hibiscus rosa-sinensis roots — rodent modelsView study →}, and a hydroalcoholic leaf extract reduced experimental colitis in rats — lowering TNF-α, myeloperoxidase, nitric oxide and lipid peroxidation while restoring SOD and glutathione ^{22Reference 22Kandhare et al. · 2012AnimalHydroalcoholic Hibiscus rosa-sinensis leaf extract in experimental colitis in rats (TNF-α ↓, antioxidant) — in vivoView study →}. The findings are consistent with the plant’s flavonoid content and point to NF-κB/TNF-α-linked suppression, but come from a small number of models without dose-response replication across labs.

Gap: Acute and single-model animal studies; no chronic-inflammation or human data, and the anti-inflammatory fraction is not standardised.

7. Neuroprotective / CNS

Separate rat studies report a spread of central effects that don’t converge on one mechanism: antidepressant-like activity of flower anthocyanidins in forced-swim and tail-suspension tests ^{26Reference 26Shewale et al. · 2012AnimalAntidepressant-like activity of anthocyanidins from Hibiscus rosa-sinensis flowers (tail-suspension/forced-swim) — miceView study →}, anxiolytic activity via ionotropic GABA-A receptor modulation ^{25Reference 25Begum et al. · 2018AnimalHibiscus rosa-sinensis mediates an anxiolytic effect via ionotropic GABA-A receptor modulation — ratView study →}, neuroprotection in a cerebral ischemia–reperfusion (oxidative-stress) model ^{27Reference 27Nade et al. · 2010AnimalNeuroprotective effect of Hibiscus rosa-sinensis in a cerebral post-ischemic reperfusion oxidative-stress model — ratView study →}, and altered neurobehaviour in a reserpine model ^{28Reference 28Nade et al. · 2009AnimalEffect of Hibiscus rosa-sinensis on reserpine-induced neurobehavioural and biochemical alterations — ratView study →}. Individually plausible and aligned with the traditional “cooling/relaxant” use, but none has been replicated or tested in humans.

Gap: Heterogeneous single-model studies; no shared mechanism, no clinical signal, and sedative claims for the tea are unverified.

8. Antimicrobial

Flower and leaf extracts show in-vitro activity against Gram-positive and Gram-negative bacteria and some fungi in disc-diffusion and MIC assays ^{5Reference 5Khan et al. · 2014In vitroAntioxidant and antibacterial activities of Hibiscus rosa-sinensis Linn. flower extracts — in vitroView study →}, and a red-flower extract inhibited antibiotic-resistant strains of Helicobacter pylori while its active flower constituents were characterised ^{23Reference 23Ngan et al. · 2021In vitroAntibacterial activity of Hibiscus rosa-sinensis red flower against antibiotic-resistant Helicobacter pylori, with constituent identification — in vitroView study →}. The activity is real in the dish but generally modest relative to reference antibiotics.

Gap: In-vitro only; no systemic or topical antimicrobial data in animals or humans, and no evidence the tea reaches inhibitory concentrations in vivo.

9. Hair growth

The traditional cosmetic use has one experimental anchor: a rat study in which leaf extract (more than flower extract) promoted hair growth, increasing follicle count and length and shortening time to regrowth ^{24Reference 24Adhirajan et al. · 2003AnimalIn-vivo and in-vitro evaluation of hair-growth potential of Hibiscus rosa-sinensis — ratView study →}. It is a single, decades-old study, but it aligns closely with the plant’s long documented use in hair oils and scalp care.

Gap: One animal study; no controlled human trial for hair loss or growth, and the effective preparation/concentration is undefined.

10. Anticancer

Signals are early and constituent-level: a flower extract inhibited chemically-induced skin papillomas in mice, an effect linked to the constituent gentisic acid and to reduced oxidative stress ^{30Reference 30Sharma et al. · 2004AnimalPrevention of two-stage skin carcinogenesis by Hibiscus rosa-sinensis extract and its constituent gentisic acid — miceView study →}, and an in-silico screen modelled flower constituents against the mTOR pathway ^{31Reference 31Rasul et al. · 2022In-silico screening of Hibiscus rosa-sinensis anti-cancer constituents targeting mTOR (molecular docking / pharmacokinetics)View study →}. These are exploratory findings from single models — far from any therapeutic claim.

Gap: In-vitro, in-silico and single-mouse-model only; no in-vivo tumour-burden replication and no human data whatsoever.

Mechanisms

Mechanism	Drives	Key compounds
Radical scavenging, metal chelation; pigment content is cultivar-dependent	antioxidant	anthocyanins — cyanidin, cyanidin-3-sophoroside
NF-κB / TNF-α ↓, prostaglandin ↓, antioxidant-enzyme support	anti-inflammatory, antioxidant	flavonols — quercetin, kaempferol, rutin
Emollient film, moisture retention, collagen / hydroxyproline support	wound healing, hair & skin	leaf polysaccharide mucilage
AMPK activation, improved insulin secretion & glycogen handling; carbohydrate-digestion inhibition	antidiabetic	flower / leaf flavonoid fraction
Endothelium-independent vasorelaxation via Ca²⁺-channel / ACE pathways	antihypertensive	flower extract (active fraction unidentified)
Anti-implantation, altered oestrous cycle, antispermatogenic	antifertility	flower / root benzene-soluble fraction

Clinical trials

No registered clinical trials were identified for Hibiscus rosa-sinensis for any indication — searches of ClinicalTrials.gov and PubMed returned only preclinical (animal and in-vitro) work. The one “HIBISCUS” trial on the registry (NCT04624659) is an unrelated sickle-cell drug study, and the human blood-pressure and lipid trials often filed under “hibiscus” are on the separate species Hibiscus sabdariffa.

Completed	Planned	Terminated	Preclinical
0	0	0	~260

Last checked: July 2026.

Dosage

Hibiscus rosa-sinensis is used as a flower tea and, traditionally, as a leaf or flower paste for the hair rather than as a dosed medicine. There is no standardised or research-derived human dose: every quantitative figure in the literature comes from animal studies (for example ~100 mg/kg of aqueous flower extract for blood pressure, or 250–500 mg/kg for glucose endpoints in rats), and these do not translate to a human amount. As a beverage it is prepared like any flower infusion — a few grams of dried flowers steeped in hot water — and for hair care the leaf mucilage or flower paste is applied topically. Amounts follow culinary and cosmetic custom, not a therapeutic target.

Safety

Hibiscus rosa-sinensis is generally low-risk as a flower tea and is consumed widely as food and beverage, but its safety profile rests almost entirely on traditional use and animal data rather than human studies. The clearest signal is reproductive: flower and root extracts show consistent anti-implantation, abortifacient and antispermatogenic activity in rodents ^{16,17,18,19Reference 16Kholkute et al. · 1977AnimalAntifertility potentiality of Hibiscus rosa-sinensis: parts of medicinal value, species and seasonal variation — ratView study →Reference 17Kholkute · 1977AnimalEffect of Hibiscus rosa-sinensis on spermatogenesis and accessory reproductive organs in rats — in vivoView study →Reference 18Singh et al. · 1982AnimalAntifertility activity of a benzene extract of Hibiscus rosa-sinensis flowers in female rats — in vivoView study →Reference 19Pal et al. · 1985AnimalFlowers of Hibiscus rosa-sinensis, a potential contragestative agent: anti-implantation effect of the benzene extract — in vivoView study →}, and in pregnant rats an aqueous flower extract impaired cardiac and reproductive function in healthy (non-diabetic) animals — even though it improved outcomes in diabetic dams ^{20Reference 20Afiune et al. · 2017AnimalEffects of Hibiscus rosa-sinensis flower aqueous extract on maternal–fetal outcomes in diabetic and non-diabetic pregnant rats — in vivoView study →}. On that basis it should be avoided in pregnancy and by anyone actively trying to conceive. An aqueous flower extract mildly lowered blood pressure in hypertensive (but not normotensive) rats ^{6Reference 6Amtaghri et al. · 2022In vitroAntihypertensive and vasorelaxant effects of Hibiscus rosa-sinensis via ACE-2 and Ca²⁺-channel pathways — in vivo/in vitro (rat)View study →}, so a theoretical additive effect with antihypertensive medication is plausible though unquantified in humans — and most human “hibiscus lowers blood pressure” data belong to the separate species H. sabdariffa, not this ornamental. Consistent antihyperglycaemic activity in diabetic rats ^{8,9,10,11,12,29Reference 8Pillai et al. · 2016AnimalHibiscus rosa-sinensis petals modulate glycogen metabolism and glucose-homeostasis signalling in diabetic rats — in vivoView study →Reference 9Pillai et al. · 2018In vitroHibiscus rosa-sinensis petals attenuate high-glucose-induced apoptotic and inflammatory signalling in pancreatic β-cells — in vitroView study →Reference 10Lingesh et al. · 2019In vitroAMPK-activating and anti-adipogenic potential of Hibiscus rosa-sinensis flower in 3T3-L1 cells — in vitroView study →Reference 11Sachdewa et al. · 2001AnimalHypoglycaemic effect of Hibiscus rosa-sinensis leaf extract in diabetic rats — in vivoView study →Reference 12Sachdewa et al. · 1999AnimalA preliminary investigation of the possible hypoglycaemic activity of Hibiscus rosa-sinensis — in vivoView study →Reference 29Ansari et al. · 2020In vitroAnti-hyperglycaemic activity of Hibiscus rosa-sinensis leaves via carbohydrate-digestion inhibition and enhanced insulin secretion — in vivo/in vitroView study →} similarly raises a theoretical additive risk with glucose-lowering drugs. No human toxicity, drug-interaction or organ-toxicity studies were identified, and lactation has not been assessed — absence of data is not evidence of safety.

Pregnancy & lactation

Avoid. This is the strongest safety signal for the plant. Flower and root extracts produce replicated anti-implantation, abortifacient and antispermatogenic effects in rodents ^{16,17,18,19Reference 16Kholkute et al. · 1977AnimalAntifertility potentiality of Hibiscus rosa-sinensis: parts of medicinal value, species and seasonal variation — ratView study →Reference 17Kholkute · 1977AnimalEffect of Hibiscus rosa-sinensis on spermatogenesis and accessory reproductive organs in rats — in vivoView study →Reference 18Singh et al. · 1982AnimalAntifertility activity of a benzene extract of Hibiscus rosa-sinensis flowers in female rats — in vivoView study →Reference 19Pal et al. · 1985AnimalFlowers of Hibiscus rosa-sinensis, a potential contragestative agent: anti-implantation effect of the benzene extract — in vivoView study →}, and an aqueous flower extract impaired cardiac and reproductive function in healthy pregnant rats ^{20Reference 20Afiune et al. · 2017AnimalEffects of Hibiscus rosa-sinensis flower aqueous extract on maternal–fetal outcomes in diabetic and non-diabetic pregnant rats — in vivoView study →}; this pharmacology is the basis for the plant’s traditional use as an emmenagogue and contraceptive. The caution extends to anyone actively trying to conceive. Lactation has not been studied — treat it as unassessed rather than safe.

References

1. Amtaghri, S., et al. (2024). A comprehensive overview of Hibiscus rosa-sinensis L.: ethnobotany, phytochemistry, therapeutic uses, pharmacology and toxicology — review. Endocr Metab Immune Disord Drug Targets. https://pubmed.ncbi.nlm.nih.gov/37218183/
2. Raza, H., et al. (2025). Hibiscus rosa-sinensis: a multifunctional flower bridging nutrition, medicine, and molecular therapeutics — review. Food Sci Nutr. https://doi.org/10.1002/fsn3.71254
3. Mejía, J. J., et al. (2023). Color, antioxidant capacity and flavonoid composition in Hibiscus rosa-sinensis cultivars — analytical (UHPLC-MS). Molecules, 28(4), 1779. https://doi.org/10.3390/molecules28041779
4. Kumar, V., et al. (2012). Antidyslipidemic and antioxidant activity of Hibiscus rosa-sinensis root extract in alloxan-induced diabetic rats — in vivo. Indian J Clin Biochem. https://doi.org/10.1007/s12291-012-0223-x
5. Khan, Z. A., et al. (2014). Antioxidant and antibacterial activities of Hibiscus rosa-sinensis Linn. flower extracts — in vitro. Pak J Pharm Sci. https://pubmed.ncbi.nlm.nih.gov/24811803/
6. Amtaghri, S., et al. (2022). Antihypertensive and vasorelaxant effects of Hibiscus rosa-sinensis via ACE-2 and Ca²⁺-channel pathways — in vivo/in vitro (rat). Cardiovasc Hematol Disord Drug Targets. https://pubmed.ncbi.nlm.nih.gov/35352670/
7. Mohan, M., et al. (2012). Effect of aqueous Hibiscus rosa-sinensis on blood pressure and metabolic alterations in fructose-induced hypertensive rats — in vivo. Nat Prod Res. https://pubmed.ncbi.nlm.nih.gov/21790490/
8. Pillai, S. S., & Mini, S. (2016). Hibiscus rosa-sinensis petals modulate glycogen metabolism and glucose-homeostasis signalling in diabetic rats — in vivo. Plant Foods Hum Nutr. https://pubmed.ncbi.nlm.nih.gov/26590603/
9. Pillai, S. S., & Mini, S. (2018). Hibiscus rosa-sinensis petals attenuate high-glucose-induced apoptotic and inflammatory signalling in pancreatic β-cells — in vitro. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/30120944/
10. Lingesh, A., et al. (2019). AMPK-activating and anti-adipogenic potential of Hibiscus rosa-sinensis flower in 3T3-L1 cells — in vitro. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/30593890/
11. Sachdewa, A., Nigam, R., & Khemani, L. D. (2001). Hypoglycaemic effect of Hibiscus rosa-sinensis leaf extract in diabetic rats — in vivo. Indian J Exp Biol. https://pubmed.ncbi.nlm.nih.gov/11495291/
12. Sachdewa, A., & Khemani, L. D. (1999). A preliminary investigation of the possible hypoglycaemic activity of Hibiscus rosa-sinensis — in vivo. Biomed Environ Sci. https://pubmed.ncbi.nlm.nih.gov/10674186/
13. Nayak, B. S., et al. (2007). Wound-healing activity of Hibiscus rosa-sinensis flower extract in rats — in vivo. Int J Low Extrem Wounds. https://pubmed.ncbi.nlm.nih.gov/17558005/
14. Bhaskar, A., & Nithya, V. (2012). Wound-healing activity of ethanolic Hibiscus rosa-sinensis flower extract in rats (excision/incision/dead-space) — in vivo. Indian J Pharmacol. https://doi.org/10.4103/0253-7613.103252
15. Shen, H. M., et al. (2017). N-butanol fraction of Hibiscus rosa-sinensis flowers enhances excisional wound healing in rats — in vivo. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/28088494/
16. Kholkute, S. D., et al. (1977). Antifertility potentiality of Hibiscus rosa-sinensis: parts of medicinal value, species and seasonal variation — rat. Planta Med. https://pubmed.ncbi.nlm.nih.gov/840927/
17. Kholkute, S. D. (1977). Effect of Hibiscus rosa-sinensis on spermatogenesis and accessory reproductive organs in rats — in vivo. Planta Med. https://pubmed.ncbi.nlm.nih.gov/854540/
18. Singh, M. P., et al. (1982). Antifertility activity of a benzene extract of Hibiscus rosa-sinensis flowers in female rats — in vivo. Planta Med. https://pubmed.ncbi.nlm.nih.gov/7089096/
19. Pal, A. K., et al. (1985). Flowers of Hibiscus rosa-sinensis, a potential contragestative agent: anti-implantation effect of the benzene extract — in vivo. Contraception. https://pubmed.ncbi.nlm.nih.gov/4085250/
20. Afiune, L. A. F., et al. (2017). Effects of Hibiscus rosa-sinensis flower aqueous extract on maternal–fetal outcomes in diabetic and non-diabetic pregnant rats — in vivo. PLoS One. https://doi.org/10.1371/journal.pone.0179785
21. Begum, Z., et al. (2018). Analgesic and anti-inflammatory activity of the ethanol extract of Hibiscus rosa-sinensis roots — rodent models. Pak J Pharm Sci. https://pubmed.ncbi.nlm.nih.gov/30150191/
22. Kandhare, A. D., et al. (2012). Hydroalcoholic Hibiscus rosa-sinensis leaf extract in experimental colitis in rats (TNF-α ↓, antioxidant) — in vivo. Asian Pac J Trop Biomed. https://doi.org/10.1016/S2221-1691(12)60053-7
23. Ngan, L. T. M., et al. (2021). Antibacterial activity of Hibiscus rosa-sinensis red flower against antibiotic-resistant Helicobacter pylori, with constituent identification — in vitro. Braz J Med Biol Res. https://doi.org/10.1590/1414-431X2020e10889
24. Adhirajan, N., et al. (2003). In-vivo and in-vitro evaluation of hair-growth potential of Hibiscus rosa-sinensis — rat. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/12963149/
25. Begum, Z., & Younus, I. (2018). Hibiscus rosa-sinensis mediates an anxiolytic effect via ionotropic GABA-A receptor modulation — rat. Metab Brain Dis. https://pubmed.ncbi.nlm.nih.gov/29372452/
26. Shewale, P. B., et al. (2012). Antidepressant-like activity of anthocyanidins from Hibiscus rosa-sinensis flowers (tail-suspension/forced-swim) — mice. Indian J Pharmacol. https://doi.org/10.4103/0253-7613.99303
27. Nade, V. S., et al. (2010). Neuroprotective effect of Hibiscus rosa-sinensis in a cerebral post-ischemic reperfusion oxidative-stress model — rat. Pharm Biol. https://pubmed.ncbi.nlm.nih.gov/20645783/
28. Nade, V. S., et al. (2009). Effect of Hibiscus rosa-sinensis on reserpine-induced neurobehavioural and biochemical alterations — rat. Indian J Exp Biol. https://pubmed.ncbi.nlm.nih.gov/19761039/
29. Ansari, P., et al. (2020). Anti-hyperglycaemic activity of Hibiscus rosa-sinensis leaves via carbohydrate-digestion inhibition and enhanced insulin secretion — in vivo/in vitro. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/32035878/
30. Sharma, S., et al. (2004). Prevention of two-stage skin carcinogenesis by Hibiscus rosa-sinensis extract and its constituent gentisic acid — mice. Eur J Cancer Prev. https://pubmed.ncbi.nlm.nih.gov/15075789/
31. Rasul, A., et al. (2022). In-silico screening of Hibiscus rosa-sinensis anti-cancer constituents targeting mTOR (molecular docking / pharmacokinetics). Mol Divers. https://pubmed.ncbi.nlm.nih.gov/36318405/